Filing Details

Accession Number:
0001127602-24-016188
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-22 07:21:21
Reporting Period:
2024-05-20
Accepted Time:
2024-05-22 07:21:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882796 Biocryst Pharmaceuticals Inc BCRX Biological Products, (No Disgnostic Substances) (2836) 621413174
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187159 Vincent Milano 4505 Emperor Blvd.
Suite 200
Durham NC 27703
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-20 15,000 $6.25 66,997 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $6.23 to $6.25. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.